Best Obesity Drug Stock: Eli Lilly, Novo Nordisk, or Viking Therapeutics?
All three of these high-flying stocks could have more room to run.
Full Article
Best Obesity Drug Stock: Eli Lilly, Novo Nordisk, or Viking Therapeutics?
Motley Fool
0 shares
1 views
You might like
Related news coverage
Should Pfizer Acquire Viking Therapeutics to Take on Eli Lilly and Novo Nordisk in the Obesity Drug Market?
Motley Fool
Viking Therapeutics just might be an attractive acquisition target for Pfizer.